Results 161 to 170 of about 336,027 (339)
The effect of exercise on plasma soluble IL-6 receptor concentration: a dichotomous response [PDF]
The aim of this article is to review current literature on the response of soluble interleukin-6 receptor to exercise and identify a potential role for sIL-6R in skeletal muscle function.
Cockburn, Emma +4 more
core
ABSTRACT Acute kidney injury (AKI) has emerged as a significant global public health concern due to its high morbidity and mortality rates. Cisplatin, a highly effective and widely used chemotherapeutic agent, is often limited in clinical application by its nephrotoxicity, particularly AKI.
Mingkang Zhang +5 more
wiley +1 more source
Chronic fatigue syndrome, exercise, cortisol and lymphadenopathy [PDF]
Riccardo Baschetti
openalex +1 more source
Heart Rate Variability Estimation from Camera Videos ABSTRACT Background Studies have shown that heart rate variability (HRV) is a predictor of the prognosis of cardiovascular diseases. Contact heartbeat monitoring equipment is widely used, especially in hospitals, and benefits from the rapidity and accuracy of the detection of physiological health ...
Lan Lan +8 more
wiley +1 more source
ABSTRACT Background Two‐month outcomes of advanced pneumatic compression device (APCD) and usual care (UC) in Head and Neck Cancer survivors with previously untreated lymphedema were compared. Methods Participants in this multisite, randomized clinical trial were randomized to APCD or UC.
Barbara A. Murphy +13 more
wiley +1 more source
The Effectiveness of Lifestyle-Focused Cognitive Behavioral Therapy versus Semantic Cognitive Restructuring Therapy on Chronic Fatigue in Patients with Irritable Bowel Syndrome [PDF]
Background and Objective: Gastrointestinal diseases are one of the most important and common chronic non-communicable diseases that impose a great economic burden and psychological pressure on society and the healthcare system.
M Akbari Ebtekar, SO Emadian, B Mirzaian
doaj
What's New? Global research has found that for people newly diagnosed with advanced non‐small cell lung cancer (NSCLC), the anti‐PD‐1 monoclonal antibody pembrolizumab on its own often leads to better results than traditional chemotherapy. The present report details long‐term findings of pembrolizumab therapy specifically among Chinese patients.
Yi‐Long Wu +14 more
wiley +1 more source

